Table 3 Association between basic characteristics and CD8+ T cells in the tumor microenvironment.
From: Prediction of CD8+ T cell infiltration in the tumor microenvironment of HGSOC patients
Variable | N = 95 | CD8+ T cells in tumor | CD8+ T cells in stroma | ||||
|---|---|---|---|---|---|---|---|
Low | High | p | Low | High | p | ||
Age | 0.936 | 0.757 | |||||
< 55 | 46 | 23 (50.0%) | 23 (50.0%) | 23 (50.0%) | 23 (50.0%) | ||
≥ 55 | 49 | 24 (49.0%) | 25 (51.0%) | 24 (49.0%) | 25 (51.0%) | ||
FIGO Stage | 0.723 | 0.375 | |||||
II | 11 | 5 (45.5%) | 6 (54.5%) | 3 (27.3%) | 8 (72.7%) | ||
III | 76 | 40 (52.6%) | 36 (47.4%) | 40 (52.6%) | 36 (47.4%) | ||
IV | 8 | 2 (25.0%) | 6 (75.0%) | 4 (50.0%) | 4 (50.0%) | ||
Neoadjuvant | 0.043 | 0.935 | |||||
YES | 37 | 13 (35.1%) | 24 (64.9%) | 19 (51.4%) | 18 (48.6%) | ||
NO | 58 | 34 (58.6%) | 24 (41.4%) | 28 (48.3%) | 30 (51.7%) | ||
Chemosensitivity | 0.330 | 0.153 | |||||
Sensitive | 68 | 31 (45.6%) | 37 (54.4%) | 30 (44.1%) | 38 (55.9%) | ||
Resistant | 27 | 16 (59.3%) | 11 (40.7%) | 17 (63.0%) | 10 (37.0%) | ||
